logo
America's Blood Centers Releases New Report Showing the Critical Role of Community Blood Centers in Expanding Prehospital Blood Programs

America's Blood Centers Releases New Report Showing the Critical Role of Community Blood Centers in Expanding Prehospital Blood Programs

Yahoo20-05-2025

Washington, DC, May 20, 2025 (GLOBE NEWSWIRE) -- America's Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation's blood supply, today released its latest report, "A Vital Resource: Community Blood Centers & The Growth of Prehospital Blood Programs." This comprehensive report provides crucial insights into the expanding role of community blood centers in supporting prehospital blood transfusion programs across the United States. It reveals that the number of community blood centers providing blood products for prehospital use has nearly doubled between 2022 and 2024, underscoring the rapid growth and increasing importance of these life-saving programs.
"Community blood centers are playing a pivotal role in the rapid expansion of prehospital blood programs across the nation. Our latest report shows an 89% increase in participating community blood centers over just two years, highlighting their commitment to expanding the availability of blood products and improving patient outcomes. As these programs continue to expand, America's Blood Centers will keep working with our members, partners, and allies to address the significant barriers that currently prevent many patients from quickly receiving the blood products they need,' said Kate Fry, CEO of America's Blood Centers.
The report reveals a significant upward trend in community blood center participation in prehospital programs. In 2022, 18 centers provided blood products for prehospital use, with 7 servicing both air and ground ambulance programs. By 2024, this number had nearly doubled to 34 centers, with 18 supporting both air and ground services. The study also highlights a dramatic increase in the supply of specific blood products for prehospital use, particularly Low Titer-O Whole Blood and Type-A Liquid Plasma units.
Based on annual surveys conducted from 2022 to 2024, the report offers valuable insights for policymakers and stakeholders in both the blood community and emergency medical services,underscoring the need for sustainable funding models, optimized inventory management, and enhanced donor recruitment strategies to support the growth of prehospital blood programs. The study notes that less than 2% of all emergency management systems carry blood and blood products today, indicating significant potential for future growth if current roadblocks were addressed.
America's Blood Centers and its members urge Congress to modernize our nation's approach to prehospital blood transfusions by updating federal insurance program payment polices to provide sufficient reimbursement for prehospital blood transfusions including updating TRICARE payment policy to remove financial barriers and allow for broader adoption of prehospital blood transfusions which supports TRICARE's mission to improve the health of the military and their families and, in turn, helps support the security of the United States. To learn more, click here. Members of the public can urge their members of Congress to take action by clicking here.
Founded in 1962, America's Blood Centers (ABC) is the national organization bringing together community-based, independent blood centers across North America. These organizations operate in more than 1,100 communities and provide close to 60 percent of the U.S. and a quarter of the Canadian blood supply. ABC member organizations serve more than 150 million people and provide blood products and services to more than 3,500 hospitals and healthcare facilities. All ABC U.S. members are 501(c)(3) organizations licensed and regulated by the U.S. Food and Drug Administration or Health Canada. For more information, visit www.AmericasBlood.org.
Attachment
"A Vital Resource: Community Blood Centers & The Growth of Prehospital Blood Programs."
CONTACT: Jeff Gohringer America's Blood Centers (202) 654-2901 jgohringer@americasblood.org

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Two Transplant Recipients Meet Their Lifesaving Donors at Gift of Life Marrow Registry Charitable Gala
Two Transplant Recipients Meet Their Lifesaving Donors at Gift of Life Marrow Registry Charitable Gala

Yahoo

timean hour ago

  • Yahoo

Two Transplant Recipients Meet Their Lifesaving Donors at Gift of Life Marrow Registry Charitable Gala

Annual Event Supports Mission to Add New Donors to Registry and Celebrates 30th Transplant Anniversary of Gift of Life Founder & CEO Jay Feinberg Transplant recipient meets stem cell donor for first time Two-year-old boy introduced to lifesaving stem cell donor NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Gift of Life Marrow Registry hosted its One Huge Night NYC Gala, where two lifesaving blood stem cell donors were united with their transplant recipients, one only two years old, for the first time. The event, held at The Lighthouse at Chelsea Piers in New York, N.Y. on June 4, 2025, brought together donors, transplant recipients, business leaders, and community members in support of Gift of Life's mission to cure blood cancer, inherited immune disorders and other diseases. The gala also marked the 30th anniversary of Jay Feinberg's transplant, the Founder and CEO of Gift of Life Marrow Registry, whose personal journey as a recipient inspired the creation of the organization. The donor-recipient pairs were introduced by Montana Tucker, an award-winning performer and social media activist, and David Blumenfeld, Principal of the Blumenfeld Development Group. The first donor and recipient pair to be introduced included Boris Semkhayev, a 30-year-old medical student from New York City and his 26-year-old recipient, Michelle Bibichayev, from Flushing, Queens, N.Y. In June 2023, Bibichayev was diagnosed with Acute Myeloid Leukemia, initially mistaking her symptoms for pregnancy-related fatigue. After routine blood work, Bibichayev learned of her life-threatening condition and feared for both her own survival and her baby's future. Faced with the need for a stem cell transplant, she felt nervous, but hopeful. Even while enduring strenuous chemotherapy and recovering from an emergency C-section, she remained optimistic. 'Thank you to Boris and Gift of Life for giving me a second chance at life,' said Bibichayev. 'I had a rare type of cancer, and I didn't think I would survive or that my son would have a mother. You saved my life.' Semkhayev joined the Gift of Life registry while attending Hunter College in 2015. When he found out he was a match for a patient, he was about to begin a new semester in medical school but immediately agreed to help. 'If your brother or sister, God forbid, needed a life-saving transplant, chances are you or anyone in your family couldn't donate,' said Semkhayev. 'But by others in your community signing up, your loved one could receive that second chance. You can be that hero. My recipient was from my own ethnic community, and that connection made all the difference.' The second pair of the evening shared an equally touching story. Lindsay Wilson, a 24-year-old recent graduate from St. Petersburg, Fla., was deeply moved to meet Logan Rich-Aiken, her two-year-old recipient from Waldorf, Md., who was battling Inherited Immune Systems Disorders. She joined Gift of Life's registry in 2020 at a donor recruitment drive held at Florida State University. She was thrilled when she got the call four-and-a-half years later letting her know that she was a match for a little boy in need. 'Each day was a reminder that committing to help save a life is nothing compared to what the recipients and their families are enduring," said Wilson. "We have the power to make a difference, and that difference can start with joining the registry.' The gala served as a platform to recognize the unwavering commitment and outstanding advocacy of several supporters. The organization's highest honor, the Partners for Life Award, was presented to Lynn Schusterman for her support and generosity through the Charles and Lynn Schusterman Family Foundation. Her long-standing partnership and collaborative recruitment efforts have inspired young people to drive positive change in the world. In addition, longtime Gift of Life supporter, board of directors member and transplant recipient Dr. Stephen Colen received the Lifetime Achievement Award, and international law firm Fried Frank was honored with the Corporate Partner Award. Wendy and Stephen B. Siegel, Gift of Life of Life Board Member and Chairman of the Board, respectively, served as Gala Chairs, Susan and Edward Blumenfeld, Board Member, served as Honorary Gala Chairs and Heller and Jeffrey Goldberg, Board Member, served as Gala Vice Chairs. The event was emceed by Ezra Fineman, a 15-year-old stem cell transplant recipient from Fairlawn, N.J. About Gift of Life Marrow RegistryGift of Life Marrow Registry is a 501(c)(3) nonprofit organization headquartered in Boca Raton, Fla. The organization, established in 1991, is dedicated to saving lives by facilitating blood stem cell and bone marrow transplants for patients with leukemia, lymphoma, and other blood-related diseases. The registry houses its own state-of-the-art stem cell collection center, biobank, and laboratory. To learn more about Gift of Life Marrow Registry, visit Media contact: Amy GlanzmanPhone: (561) 982-2900; Email: aglanzman@ Photos accompanying this announcement are available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Medical Terminology Software Outlook 2029: Key Trends, Vendor Insights, and Global Opportunities
Medical Terminology Software Outlook 2029: Key Trends, Vendor Insights, and Global Opportunities

Yahoo

timean hour ago

  • Yahoo

Medical Terminology Software Outlook 2029: Key Trends, Vendor Insights, and Global Opportunities

Key growth drivers in the medical terminology software market include minimizing medical errors and the rising demand for terminology software. The report covers market size, trends, vendor analysis, and geographical segmentation, providing insights on the evolving market landscape for healthcare providers, payers, and IT vendors. Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Medical Terminology Software Market 2025-2029" has been added to offering. The medical terminology software market is poised for significant expansion, with projections indicating a growth of USD 3.80 billion from 2024 to 2029, at an impressive CAGR of 26.3%. This comprehensive report offers an in-depth analysis of market size and forecasts, emerging trends, growth drivers, and challenges, along with a detailed vendor analysis covering approximately 25 prominent vendors. The report presents a current market scenario, incorporating the latest insights on trends and drivers, and evaluates the overall market environment. The industry's growth is significantly driven by a heightened focus on reducing medical errors and a rising global demand for robust medical terminology software, fueled by discrepancies in terminology content worldwide. The analysis highlights the growing adoption of healthcare information technology as a significant growth area for the market. Additionally, the rise in medical tourism and increasing strategic alliances with new product launches are expected to create substantial market demand. The medical terminology software market segmentation includes: By End-user Healthcare providers Healthcare payers Healthcare IT vendors By Type Services Platforms By Application Data integration Data aggregation Reimbursement Clinical trials By Geographical Landscape North America Europe APAC South America Middle East and Africa Areas covered within the report: Medical Terminology Software Market sizing Medical Terminology Software Market forecast Medical Terminology Software Market industry analysis The report's robust vendor analysis is designed to help clients enhance their market position. Key players studied include: 3M Co. Apelon Inc. B2i Healthcare Pte Ltd. BITAC MAP SL BT Clinical Computing Clinical Architecture LLC Epic Systems Corp. Henry Schein Inc. HiveWorx Intelligent Medical Objects Inc. Medaara Healthcare Solutions Medocomp Systems Inc. Regenstrief Institute Rhapsody SNOMED International Spellex Corp. West Coast Informatics Wolters Kluwer NV Additionally, the report examines upcoming trends and challenges poised to influence market growth, offering strategic insights for leveraging future Topics Covered: Market Analysis Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Criticality of inputs and Factors of differentiation Factors of disruption Impact of drivers and challenges Market Landscape Market ecosystem Market characteristics Value chain analysis Market Sizing Market definition Market segment analysis Market size 2024 Market outlook: Forecast for 2024-2029 Historic Market Size Global Medical Terminology Software Market 2019 - 2023 End-user segment analysis 2019 - 2023 Type segment analysis 2019 - 2023 Application segment analysis 2019 - 2023 Geography segment analysis 2019 - 2023 Country segment analysis 2019 - 2023 Qualitative Analysis Impact of AI on Global Medical Terminology Software Market Five Forces Analysis Five forces summary Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition Market Segmentation by End-user Market segments Comparison by End-user Healthcare providers - Market size and forecast 2024-2029 Healthcare payers - Market size and forecast 2024-2029 Healthcare IT vendors - Market size and forecast 2024-2029 Market opportunity by End-user Market Segmentation by Type Market segments Comparison by Type Services - Market size and forecast 2024-2029 Platforms - Market size and forecast 2024-2029 Market opportunity by Type Market Segmentation by Application Market segments Comparison by Application Data integration - Market size and forecast 2024-2029 Data aggregation - Market size and forecast 2024-2029 Reimbursement - Market size and forecast 2024-2029 Clinical trials - Market size and forecast 2024-2029 Market opportunity by Application Customer Landscape Geographic Landscape Geographic segmentation Geographic comparison North America - Market size and forecast 2024-2029 Europe - Market size and forecast 2024-2029 APAC - Market size and forecast 2024-2029 South America - Market size and forecast 2024-2029 Middle East and Africa - Market size and forecast 2024-2029 Market opportunity By Geographical Landscape Drivers, Challenges, and Opportunity/Restraints Market drivers Market challenges Impact of drivers and challenges Market opportunities/restraints Competitive Landscape Competitive Landscape Landscape disruption Industry risks Competitive Analysis Companies profiled Company ranking index Market positioning of companies For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY

Yahoo

timean hour ago

  • Yahoo

Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY

REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Global Healthcare Conference 2025, which will be held in New York, New York June 3-5, 2025. Members of the management team will host one-on-one meetings at the conference. Dr. Balaji Prasad, Chief Strategy Officer will deliver a presentation with recent business updates at the conference on Thursday June 5, 2025, at 10:30 am-11:00 am EDT (14:30-15:00 GMT / 16:30-17:00 CET). A live video webcast of the presentation will be available to the general public and can be accessed at After the event, a recording will be available for replay for 90 days. About AlvotechAlvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products, and services, enabled by a fully integrated approach and broad in-house capabilities. Alvotech has launched two biosimilars. The current development pipeline includes biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. Alvotech's commercial partners include Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd. (US), STADA Arzneimittel AG (EU), Fuji Pharma Co., Ltd (Japan), Advanz Pharma (EEA, UK, Switzerland, Canada, Australia and New Zealand), Dr. Reddy's (EEA, UK and US), Biogaran (FR), Cipla/Cipla Gulf/Cipla Med Pro (Australia, New Zealand, South Africa/Africa), JAMP Pharma Corporation (Canada), Yangtze River Pharmaceutical (Group) Co., Ltd. (China), DKSH (Taiwan, Hong Kong, Cambodia, Malaysia, Singapore, Indonesia, India, Bangladesh and Pakistan), YAS Holding LLC (Middle East and North Africa), Abdi Ibrahim (Turkey), Kamada Ltd. (Israel), Mega Labs, Stein, Libbs, Tuteur and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines, and South Korea). Each commercial partnership covers a unique set of product(s) and territories. Except as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made available by its partners. For more information, please visit Please visit our investor portal, and our website or follow us on social media on LinkedIn, Facebook, Instagram, and YouTube. ALVOTECH INVESTOR RELATIONS AND GLOBAL COMMUNICATIONS Benedikt Stefansson, in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store